1. Search Result
Search Result
Results for "

monohydroxy fatty acids

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

3

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-113884A

    (±)-13-HODE

    Endogenous Metabolite Metabolic Disease
    (±)13-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid. It is the principle hydroxylated fatty acid in human psoriatic skin scales, with a mean concentration of 17 ng/mg.
    (±)-Coriolic acid
  • HY-113943A

    (±)9-HETE

    Endogenous Metabolite Others
    9-HETE, a monohydroxy fatty acid, is the lipoxygenase metabolite of arachidonic acid (HY-109590) .
    9-HETE
  • HY-121987A

    Lipoxygenase Inflammation/Immunology
    (±)15-HEDE is a racemic mixture of the monohydroxy fatty acids 15(R)-HEDE and 15(S)-HEDE. 15-HEDE is formed from eicosadienoic acid in macrophages. It inhibits 5-lipoxygenase (5-LO; IC50=35 μM).
    (±)15-HEDE
  • HY-W747548

    Lipoxygenase Leukotriene Receptor Inflammation/Immunology
    12(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 12-LO. Unstimulated neutrophils metabolize 12(S)-HEPE to 12(S),20-diHEPE, whereas stimulated neutrophils produce 5(S),12(S)-HEPE via the 5-lipoxygenase pathway. The competitive action of 12(S)-HEPE with arachidonic acid as a substrate for 5-LO in the formation of leukotrienes may provide a basis for the anti-inflammatory potential of ω-3 fatty acids.
    12(S)-HEPE
  • HY-W552832

    Endogenous Metabolite Metabolic Disease
    10-Oxooctadecanoic acid is an oxo fatty acid that can be isolated from mature adipocere in human remains that have been deceased for 6 months. 10-Oxooctadecanoic acid, together with monohydroxy fatty acids, promotes the enhancement and stabilization of adipocere formation .
    10-Oxooctadecanoic acid
  • HY-130675

    (±)15-hydroxyeicosapentaenoic acid; 15-OHEPA

    Lipoxygenase Bacterial Metabolic Disease
    (±)15-HEPE is a racemic mixture of the monohydroxy fatty acids 15(R)-HEPE and 15(S)-HEPE (HY-130675A). (±)15-HEPE is active against P. acnes and S. aureus (MICs = 128 and 512 mg/L, respectively). It inhibits aggregation of isolated rat neutrophils induced by the formyl peptide receptor agonist fMLP (IC50 = 4.7 µM). Bronchoalveolar lavage fluid (BALF) levels of (±)15-HEPE are increased in patients with allergic asthma or COVID-19.
    (±)15-HEPE
  • HY-112653A

    8-Hydroxy-5(Z),9(E),11(Z),14(Z)-eicosatetraenoic acid

    Endogenous Metabolite Metabolic Disease
    (±)8-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of Arachidonic acid (HY-109590). The biological activity of (±)8-HETE is likely to resemble that of its constituent enantiomers (8(R)-HETE and 8(S)-HETE).
    (±)8-HETE
  • HY-130310B

    11-hydroxy-12,14-Eicosadienoic acid

    COX Metabolic Disease
    (±)11-HEDE is a racemic mixture of the monohydroxy fatty acids 11(S)-HEDE and 11(R)-HEDE. 11-HEDE is formed from eicosadienoic acid by cyclooxygenase (COX) and in macrophages.
    (±)11-HEDE
  • HY-113943

    Endogenous Metabolite Others
    9(S)-HETE is the S isomer of 9-HETE (HY-113943A). 9-HETE, a monohydroxy fatty acid, is the lipoxygenase metabolite of arachidonic acid (HY-109590) .
    9(S)-HETE
  • HY-113281

    Endogenous Metabolite Metabolic Disease
    5-Hydroxyhexanoic acid is a normal monohydroxy carboxylic acid degradation product of
    fatty acids with medium chain lengths (particularly hexanoic acid). 5-Hydroxyhexanoic acid functions as a predictor of early renal functional decline in type 2 diabetes with microalbuminuria .
    5-Hydroxyhexanoic acid

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: